SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Takeda Pharmaceutical Co Ltd for the reporting period ending December 31, 2023. The document discloses the company's holdings in equity securities, detailing the number of shares, value, and voting authority for various issuers.
Key Financial Metrics
The filing does not contain Takeda Pharmaceutical Co Ltd's internal financial performance metrics (revenue, profit, cash flow, margins, debt, or liquidity). Instead, it lists the Value of specific equity positions held by the company. Notable holdings include:
- Denali Therapeutics Inc.: 86,946,352 shares valued at $4,214,559.
- Phathom Pharmaceuticals, Inc.: 77,352,796 shares valued at $7,459,286.
- HilleVax, Inc.: 107,920,600 shares valued at $6,724,000.
- Ovid Therapeutics Inc.: Two positions totaling 24,253,027 shares valued at $7,531,996.
- Shattuck Labs, Inc.: 14,907,818 shares valued at $2,090,858.
Material Changes
The filing text does not provide comparative data for the prior period; therefore, material changes in holdings versus the previous quarter cannot be determined from this document alone.
Guidance, Outlook, and Risks
This form is a regulatory disclosure of holdings and does not contain management commentary, financial guidance, outlook, or specific risk factors regarding Takeda's operations. The filing includes a standard disclaimer that the SEC has not reviewed the information for accuracy or completeness.
Investor Verification Checklist
- Verify the total aggregate value of all disclosed positions to assess the scale of Takeda's external equity investments.
- Confirm the voting authority status (Sole, Shared, or None) for significant positions like Denali Therapeutics and Phathom Pharmaceuticals.
- Check subsequent filings to determine if these positions were maintained, increased, or liquidated in the following quarter.
- Review Takeda's primary financial reports (10-K or 20-F) for actual corporate revenue and profit data, as this 13F form does not provide them.